Literature DB >> 6162168

Brain locations controlling the behavioral effects of chronic amphetamine intoxication.

R Hitzemann, J Wu, D Hom, H Loh.   

Abstract

Rats were administered D-amphetamine repeatedly for 4 days. After day 1 of treatment, the amphetamine-induced increases in ambulation, rearing, and stereotyped activity were augmented. However, after 4 days treatment, the rearing and ambulatory responses became attenuated while the stereotyped activities remained augmented. Micro-injection studies revealed that both the augmentation and attenuation of nonstereotyped ambulation were generated from the nucleus accumbens. The augmentation of stereotyped behaviors was generated from the caudate nucleus. Chronically treated animals who were administered 0.7 but not 1.0 mg/kg apomorphine showed augmented behavioral response. Chronic amphetamine treatment significantly decreased (3H) spiroperidol binding in both the nucleus accumbens and caudate nucleus. However, no effect on the DA-stimulated adenyl cyclase activity was observed in either brain region. It is concluded that repeated D-amphetamine administration selectively augments and attenuates D-amphetamine-induced behaviors and that these selective effects are mediated by different dopamine systems.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6162168     DOI: 10.1007/BF00433812

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Dopamine receptor binding in the corpus striatum of mammalian brain.

Authors:  D R Burt; S J Enna; I Creese; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

2.  A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.

Authors:  P Jenner; P N Elliott; A Clow; C Reavill; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1978-01       Impact factor: 3.765

Review 3.  Dopamine-sensitive adenylyl cyclase: a receptor mechanism for dopamine.

Authors:  J W Kebabian
Journal:  Adv Biochem Psychopharmacol       Date:  1978

4.  The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro.

Authors:  J L Howard; B T Large; S Wedley; I A Pullar
Journal:  Life Sci       Date:  1978-08-14       Impact factor: 5.037

Review 5.  Brain receptors for dopamine and neuroleptics.

Authors:  P Seeman; M Titeler; J Tedesco; P Weinreich; D Sinclair
Journal:  Adv Biochem Psychopharmacol       Date:  1978

6.  The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat.

Authors:  I Creese; S D Iversen
Journal:  Psychopharmacologia       Date:  1974

7.  Effects of some psychotropic drugs on dopamine synthesis in the rat striatum.

Authors:  M J Besson; A Cheramy; J Glowinski
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

8.  [Contribution to the clinical study of a new neuroleptic: sulpiride].

Authors:  J C Benoit; G Delagrange; A Richou; G Souchon; I Sow; P Sivadon
Journal:  Sem Hop       Date:  1969-03-26

9.  A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.

Authors:  P Jenner; A Clow; C Reavill; A Theodorou; C D Marsden
Journal:  Life Sci       Date:  1978-08-14       Impact factor: 5.037

10.  Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Life Sci       Date:  1975-09-15       Impact factor: 5.037

View more
  9 in total

1.  Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.

Authors:  N S Gray; A D Pickering; D R Hemsley; S Dawling; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Development and persistence of methamphetamine-conditioned hyperactivity in Swiss-Webster mice.

Authors:  Anthony Sean Rauhut; Victoria Bialecki
Journal:  Behav Pharmacol       Date:  2011-06       Impact factor: 2.293

3.  Specific opioid-amphetamine interactions in the caudate putamen.

Authors:  S K Woo; R J Hitzemann; H H Loh
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 4.  Behavioural tolerance to amphetamine and other psychostimulants: the case for considering behavioural mechanisms.

Authors:  C Demellweek; A J Goudie
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol.

Authors:  G V Rebec; E E Peirson; F A McPherson; K Brugge
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 6.  Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function.

Authors:  Neil M Richtand
Journal:  Neuropsychopharmacology       Date:  2006-07-19       Impact factor: 7.853

7.  Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.

Authors:  I Weiner; A Izraeli-Telerant; J Feldon
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.

Authors:  M Toru; N Mataga; M Takashima; T Nishikawa
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Differential effects of chronic treatment with chlorpromazine versus cocaine on behavioral responsiveness to nigral GABA receptor stimulation.

Authors:  S E Bachus; K Gale
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.